{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T23:10:42Z","timestamp":1776726642887,"version":"3.51.2"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81100369"],"award-info":[{"award-number":["81100369"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Planning Project of Guangzhou City","award":["11C22130682"],"award-info":[{"award-number":["11C22130682"]}]},{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"crossref","award":["2013B021800084"],"award-info":[{"award-number":["2013B021800084"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"crossref","award":["S2012040007921"],"award-info":[{"award-number":["S2012040007921"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010883","name":"Administration of Traditional Chinese Medicine of Guangdong Province","doi-asserted-by":"crossref","award":["20121156"],"award-info":[{"award-number":["20121156"]}],"id":[{"id":"10.13039\/501100010883","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.bbrc.2014.10.107","type":"journal-article","created":{"date-parts":[[2014,10,27]],"date-time":"2014-10-27T18:33:43Z","timestamp":1414434823000},"page":"423-428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Targeting miR-21 sensitizes Ph+ ALL Sup-b15 cells to imatinib-induced apoptosis through upregulation of PTEN"],"prefix":"10.1016","volume":"454","author":[{"given":"Wei-Zhang","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-Hua","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiao-Hong","family":"Pu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man-Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Rong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-Qing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Wen","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Yong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Bao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2014.10.107_b0005","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(12)62187-4","article-title":"Acute lymphoblastic leukaemia","volume":"381","author":"Inaba","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2014.10.107_b0010","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/cncr.25690","article-title":"Philadelphia chromosome-positive acute lymphoblastic leukemia: current treatment and future perspectives","volume":"117","author":"Lee","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.bbrc.2014.10.107_b0015","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","article-title":"The molecular biology of chronic myeloid leukemia","volume":"96","author":"Deininger","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2014.10.107_b0020","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","article-title":"Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia","volume":"355","author":"Druker","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2014.10.107_b0025","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2014.10.107_b0030","doi-asserted-by":"crossref","first-page":"6170","DOI":"10.1038\/sj.onc.1209911","article-title":"MicroRNAs and the hallmarks of cancer","volume":"25","author":"Dalmay","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2014.10.107_b0035","doi-asserted-by":"crossref","first-page":"11111","DOI":"10.1158\/0008-5472.CAN-07-2858","article-title":"MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy","volume":"67","author":"Weidhaas","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2014.10.107_b0040","first-page":"997","article-title":"MicroRNA-181a sensitizes human malignant glioma U87MG cells to radiation by targeting Bcl-2","volume":"23","author":"Chen","year":"2010","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbrc.2014.10.107_b0045","doi-asserted-by":"crossref","first-page":"e47449","DOI":"10.1371\/journal.pone.0047449","article-title":"Silencing of microRNA-21 confers radio-sensitivity through inhibition of the PI3K\/AKT pathway and enhancing autophagy in malignant glioma cell lines","volume":"7","author":"Gwak","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2014.10.107_b0050","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1101\/gr.098046.109","article-title":"Reprogramming of miRNA networks in cancer and leukemia","volume":"20","author":"Volinia","year":"2010","journal-title":"Genome Res."},{"key":"10.1016\/j.bbrc.2014.10.107_b0055","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.4161\/cbt.10.12.14252","article-title":"MicroRNA-21: a novel therapeutic target in human cancer","volume":"10","author":"Pan","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bbrc.2014.10.107_b0060","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1756-8722-4-6","article-title":"BCR-ABL1-independent PI3Kinase activation causing imatinib-resistance","volume":"4","author":"Quentmeier","year":"2011","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbrc.2014.10.107_b0065","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1016\/j.febslet.2008.06.048","article-title":"Abrogation of G2\/M arrest sensitizes curcumin-resistant hepatoma cells to apoptosis","volume":"582","author":"Wang","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrc.2014.10.107_b0070","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ygyno.2014.01.034","article-title":"The inhibition of miR-21 promotes apoptosis and chemosensitivity in ovarian cancer","volume":"132","author":"Chan","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbrc.2014.10.107_b0075","doi-asserted-by":"crossref","first-page":"e103698","DOI":"10.1371\/journal.pone.0103698","article-title":"MicroRNA-21 (miR-21) regulates cellular proliferation, invasion, migration, and apoptosis by targeting PTEN, RECK and Bcl-2 in lung squamous carcinoma, Gejiu City, China","volume":"9","author":"Xu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2014.10.107_b0080","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","article-title":"Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification","volume":"293","author":"Gorre","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2014.10.107_b0085","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1182\/blood-2003-12-4276","article-title":"Active transport of imatinib into and out of cells: implications for drug resistance","volume":"104","author":"Thomas","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2014.10.107_b0090","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/ng1343","article-title":"Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia","volume":"36","author":"Hu","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2014.10.107_b0095","doi-asserted-by":"crossref","first-page":"e83510","DOI":"10.1371\/journal.pone.0083510","article-title":"Inhibition of PI3K\/mTOR overcomes nilotinib resistance in BCR-ABL1 positive leukemia cells through translational down-regulation of MDM2","volume":"8","author":"Ding","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2014.10.107_b0100","doi-asserted-by":"crossref","first-page":"8108","DOI":"10.1158\/0008-5472.CAN-10-2579","article-title":"IFN induces miR-21 through a signal transducer and activator of transcription 3-dependent pathway as a suppressive negative feedback on IFN-induced apoptosis","volume":"70","author":"Yang","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2014.10.107_b0105","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1182\/blood-2007-03-081133","article-title":"Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer","volume":"110","author":"Loffler","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2014.10.107_b0110","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.gastro.2007.05.022","article-title":"MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer","volume":"133","author":"Meng","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2014.10.107_b0115","doi-asserted-by":"crossref","first-page":"8157","DOI":"10.1158\/0008-5472.CAN-09-1996","article-title":"MicroRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells","volume":"69","author":"Wang","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2014.10.107_b0120","doi-asserted-by":"crossref","first-page":"26533","DOI":"10.1074\/jbc.M109.027466","volume":"284","author":"Bourguignon","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2014.10.107_b0125","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1158\/1541-7786.MCR-09-0465","article-title":"Overexpression of miR-21 promotes an in vitro metastatic phenotype by targeting the tumor suppressor RHOB","volume":"8","author":"Connolly","year":"2010","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbrc.2014.10.107_b0130","doi-asserted-by":"crossref","first-page":"10144","DOI":"10.1073\/pnas.1103735108","article-title":"Loss of the miR-21 allele elevates the expression of its target genes and reduces tumorigenesis","volume":"108","author":"Ma","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2014.10.107_b0135","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/cr.2009.72","article-title":"Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma","volume":"19","author":"Liu","year":"2009","journal-title":"Cell Res."},{"key":"10.1016\/j.bbrc.2014.10.107_b0140","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/hep.22838","article-title":"MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3","volume":"49","author":"Selaru","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2014.10.107_b0145","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1074\/jbc.M707224200","article-title":"Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells","volume":"283","author":"Frankel","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2014.10.107_b0150","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1182\/blood-2011-07-366203","article-title":"The PI3K\/PKB signaling module as key regulator of hematopoiesis: implications for therapeutic strategies in leukemia","volume":"119","author":"Polak","year":"2012","journal-title":"Blood"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14019172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14019172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T05:12:30Z","timestamp":1598418750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X14019172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0006291X14019172"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.10.107","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting miR-21 sensitizes Ph+ ALL Sup-b15 cells to imatinib-induced apoptosis through upregulation of PTEN","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.10.107","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}